View drug registration information details.


ItemsRegistration information
ID440
No440
Brand NameBEZARTAN TABLET 300 MG
IngredientsIRBESARTAN 300 MG
Dosage FormFILM COATED TABLET
Primary PackagingPVDC-BLISTER
StorageSTORE AT THE TEMPERATURE BELOW 30 C AND PROTECT FROM LIGHT
Shelf Life2 YEARS
Pack SizeBOX OF 3 X 10'S
Dispensing CategoryPRESCRIPTION
ATC ClassificationC09CA04
Pharmaceutical ClassANTIHYPERTENSIVE
IndicationsTREATMENT OF ESSENTIAL HYPERTENSION, TREATMENT OF DIABETIC NEPHROPATHY WITH AN ELEVATED SERUM CREATININE AND PROTEINURIA (>300 MG/DAY) IN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION
ContraindicationsHYPERSENSITIVITY, SECOND AND THIRD TRIMESTER OF PREGNANCY, WITH ALISKIREN-CONTAINING PRODUCT IN PATIENTS WITH DIABETE MELLITUS OR RENAL IMPAIREMENT
Side EffectsHYPERKALAEMIA, DIZZINESS, ORTHOSTATIC DIZZINESS, NAUSEA, MUSCULOSKELETAL PAIN, FATIQUE
Unit Price
EDL No
DescriptionWHITE, OVAL-SHAPED, WITH SCORED ON ONE SIDE AND FILM COATED TABLET.
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerDUOPHARMA MANUFACTURING(BANGI)SDN.BHD.
CountryMALAYSIA
Import Registration NoMAL19056120AZ
Import Registration Date2019-05-30
ActivityCERTIFICATE RELEASED
Applied Date2021-12-03
FDD Registration No04 I 5476/23
FDD Registration Date2023-04-25
Expiry Date2026-04-24

Back to drug list